A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 31, Issue 12, Pages 1519-1526
Publisher
SAGE Publications
Online
2017-06-28
DOI
10.1177/0269881117715597
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies
- (2017) X Xiao et al. MOLECULAR PSYCHIATRY
- An update on the physiological and therapeutic relevance of GPCR oligomers
- (2017) Batoul Farran PHARMACOLOGICAL RESEARCH
- Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci
- (2017) Atsushi Takata et al. Nature Communications
- Advances in the genetics of schizophrenia: toward a network and pathway view for drug discovery
- (2016) David A. Collier et al. Annals of the New York Academy of Sciences
- Genome-wide changes in lncRNA, splicing and regional gene expression patterns in autism
- (2016) Neelroop N. Parikshak et al. NATURE
- A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus
- (2016) Ming Li et al. NATURE MEDICINE
- Gene expression elucidates functional impact of polygenic risk for schizophrenia
- (2016) Menachem Fromer et al. NATURE NEUROSCIENCE
- Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study
- (2016) Aintzane García-Bea et al. SCHIZOPHRENIA RESEARCH
- RNA splicing is a primary link between genetic variation and disease
- (2016) Yang I. Li et al. SCIENCE
- Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia
- (2015) Bruce J. Kinon et al. BIOLOGICAL PSYCHIATRY
- Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function
- (2015) Marco Scarselli et al. FEBS Journal
- Conformational dynamics of a class C G-protein-coupled receptor
- (2015) Reza Vafabakhsh et al. NATURE
- Recent genetic findings in schizophrenia and their therapeutic relevance
- (2014) Paul J Harrison JOURNAL OF PSYCHOPHARMACOLOGY
- Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse
- (2014) S H Kim et al. MOLECULAR PSYCHIATRY
- Translating Human Genetics into Novel Treatment Targets for Schizophrenia
- (2014) Christian R. Schubert et al. NEURON
- Expression ofZNF804Ain Human Brain and Alterations in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
- (2014) Ran Tao et al. JAMA Psychiatry
- Genetic Association, Mutation Screening, and Functional Analysis of a Kozak Sequence Variant in the Metabotropic Glutamate Receptor 3 Gene in Bipolar Disorder
- (2013) Radhika Kandaswamy et al. JAMA Psychiatry
- Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins
- (2011) Ana C Magalhaes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interdomain movements in metabotropic glutamate receptor activation
- (2011) S. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
- (2010) Colleen M. Niswender et al. Annual Review of Pharmacology and Toxicology
- Genetic Neuropathology of Schizophrenia: New Approaches to an Old Question and New Uses for Postmortem Human Brains
- (2010) Joel E. Kleinman et al. BIOLOGICAL PSYCHIATRY
- G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function
- (2009) Graeme Milligan BRITISH JOURNAL OF PHARMACOLOGY
- Group II metabotropic glutamate receptors and schizophrenia
- (2009) José L. Moreno et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia
- (2008) PJ Harrison et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Identification of a serotonin/glutamate receptor complex implicated in psychosis
- (2008) Javier González-Maeso et al. NATURE
- Expression of a GRM3 Splice Variant is Increased in the Dorsolateral Prefrontal Cortex of Individuals Carrying a Schizophrenia Risk SNP
- (2008) Leah J Sartorius et al. NEUROPSYCHOPHARMACOLOGY
- Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors
- (2008) Richard Einstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now